SeongShick Ryu

424 citations
10 papers · 57 indexed · h-index 4
Topics
Fibroblast Growth Factor Research (2 papers)Ubiquitin and proteasome pathways (2 papers)Cancer-related Molecular Pathways (2 papers)

In The Last Decade

SeongShick Ryu

10 papers receiving 57 citations

Peers

SeongShick Ryu
Comparison fields: 5 of 25
  • Molecular Biology 47
  • Oncology 22
  • Organic Chemistry 10
  • Immunology and Allergy 9
  • Pulmonary and Respiratory Medicine 6
Replace Kelsey Pendleton with:
Kelsey Pendleton United States
Heribert Arnhof Austria
Janice Schindler‐Horvat United States
Daniele Casero Italy
Attila Teoman Australia
Kevin A. Buczkowski United States
D. O’Donnell Ireland
Maximilian Desole Germany
Natalie Stratton United Kingdom
Mark J. Chicarelli United States
SeongShick Ryu relative to Kelsey Pendleton United States Kelsey Pendleton's profile →
Citations per field
00.5×
Kelsey Pendleton · 1×
Citations per year

Countries citing papers authored by SeongShick Ryu

Since Specialization
Citations

This map shows the geographic impact of SeongShick Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SeongShick Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SeongShick Ryu more than expected).

Fields of papers citing papers by SeongShick Ryu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SeongShick Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SeongShick Ryu. The network helps show where SeongShick Ryu may publish in the future.

Co-authorship network of co-authors of SeongShick Ryu

This figure shows the co-authorship network connecting the top 25 collaborators of SeongShick Ryu. A scholar is included among the top collaborators of SeongShick Ryu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SeongShick Ryu. SeongShick Ryu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 2
2 2
3 7
4 6
5 2
6 2
7 1
8 7
9 27
10 1

About SeongShick Ryu

SeongShick Ryu is a scholar working on Gastroenterology, Immunology and Allergy and Cancer Research, having authored 10 papers that have together received 57 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (2 papers), Ubiquitin and proteasome pathways (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Immunology and Allergy (9 citations), Oncology (22 citations) and Molecular Biology (47 citations). SeongShick Ryu has collaborated with scholars based in South Korea, United States and Italy. Frequent co-authors include Taebo Sim, Younghoon Kim, Injae Shin, Nam Doo Kim, Hanna Cho, Nam Hoon Kwon, Sung‐Hoon Kim, Hojong Yoon, Chiman Song and Jiwon Lee. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026